These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20521907)

  • 41. Development and characterization of enteric-coated immediate-release pellets of aceclofenac by extrusion/spheronization technique using kappa-carrageenan as a pelletizing agent.
    Kilor VA; Sapkal NP; Awari JG; Shewale BD
    AAPS PharmSciTech; 2010 Mar; 11(1):336-43. PubMed ID: 20195805
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extrusion/spheronization--effect of moisture content and spheronization time on pellet characteristics.
    Iyer RM; Augsburger LL; Pope DG; Shah RD
    Pharm Dev Technol; 1996 Dec; 1(4):325-31. PubMed ID: 9552316
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design and optimization of disintegrating pellets of MCC by non-aqueous extrusion process using statistical tools.
    Gurram RK; Gandra S; Shastri NR
    Eur J Pharm Sci; 2016 Mar; 84():146-56. PubMed ID: 26812204
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preparation of lovastatin matrix sustained-release pellets by extrusion-spheronization combined with microcrystal dispersion technique.
    He H; Shi B; Cai C; Tang X
    Arch Pharm Res; 2011 Nov; 34(11):1931-8. PubMed ID: 22139692
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined effects of wetting, drying, and microcrystalline cellulose type on the mechanical strength and disintegration of pellets.
    Balaxi M; Nikolakakis I; Kachrimanis K; Malamataris S
    J Pharm Sci; 2009 Feb; 98(2):676-89. PubMed ID: 18548618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The preparation of pellets containing non-ionic surfactants by extrusion/spheronization.
    Podczeck F; Alessi P; Newton JM
    Int J Pharm; 2008 Sep; 361(1-2):33-40. PubMed ID: 18571347
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of the surface tension of wet massing liquid on the functionality of microcrystalline cellulose as pelletization aid.
    Elsergany RN; Lenhart V; Kleinebudde P
    Eur J Pharm Biopharm; 2020 Aug; 153():285-296. PubMed ID: 32599270
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of the degree of polymerization on the behavior of cellulose during homogenization and extrusion/spheronization.
    Kleinebudde P; Jumaa M; El Saleh F
    AAPS PharmSci; 2000; 2(3):E21. PubMed ID: 11741237
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immediate release pellets with lipid binders obtained by solvent-free cold extrusion.
    Krause J; Thommes M; Breitkreutz J
    Eur J Pharm Biopharm; 2009 Jan; 71(1):138-44. PubMed ID: 18805483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insights into the functionality of pelletization aid in pelletization by extrusion-spheronization.
    Sarkar S; Heng PW; Liew CV
    Pharm Dev Technol; 2013 Feb; 18(1):61-72. PubMed ID: 21981607
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Formulation of lipid bearing pellets as a delivery system for poorly soluble drugs.
    Chopra S; Venkatesan N; Betageri GV
    Int J Pharm; 2013 Mar; 446(1-2):136-44. PubMed ID: 23422274
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug solubility effects on predicting optimum conditions for extrusion and spheronization of pellets.
    Hileman GA; Upadrashta SM; Neau SH
    Pharm Dev Technol; 1997 Feb; 2(1):43-52. PubMed ID: 9552430
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Melt-in-Mouth Multi-particulate System for the Treatment of ADHD: A Convenient Platform for Pediatric Use.
    Patadia J; Tripathi R; Joshi A
    AAPS PharmSciTech; 2016 Aug; 17(4):878-90. PubMed ID: 26392403
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dual coating of swellable and rupturable polymers on glipizide loaded MCC pellets for pulsatile delivery: formulation design and in vitro evaluation.
    Yadav D; Survase S; Kumar N
    Int J Pharm; 2011 Oct; 419(1-2):121-30. PubMed ID: 21807081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The behavior of different carrageenans in pelletization by extrusion/spheronization.
    Thommes M; Kleinebudde P
    Pharm Dev Technol; 2008; 13(1):27-35. PubMed ID: 18300097
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation.
    Chatchawalsaisin J; Podczeck F; Newton JM
    Int J Pharm; 2004 May; 275(1-2):41-60. PubMed ID: 15081137
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug release from MCC- and carrageenan-based pellets: experiment and theory.
    Kranz H; Jürgens K; Pinier M; Siepmann J
    Eur J Pharm Biopharm; 2009 Oct; 73(2):302-9. PubMed ID: 19465119
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The preparation of pellets containing a surfactant or a mixture of mono- and di-gylcerides by extrusion/spheronization.
    Newton JM; Pinto MR; Podczeck F
    Eur J Pharm Sci; 2007 Mar; 30(3-4):333-42. PubMed ID: 17223021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of cellulose ether containing excipients with microcrystalline cellulose for the production of pellets containing metformin hydrochloride by the process of extrusion-spheronization.
    Gouldson MP; Deasy PB
    J Microencapsul; 1997; 14(2):137-53. PubMed ID: 9132466
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Importance of the fraction of microcrystalline cellulose and spheronization speed on the properties of extruded pellets made from binary mixtures.
    Kleinebudde P; Schröder M; Schultz P; Müller BW; Waaler T; Nymo L
    Pharm Dev Technol; 1999 Aug; 4(3):397-404. PubMed ID: 10434285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.